You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NTRK Gene Rearrangements

Showing 1 - 25 of 6,004
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn More About NTRK Gene Fusion Positive in Solid Tumor in

Not yet recruiting
  • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
  • No Drug
  • Multiple Locations, Japan
    Many Locations
Mar 20, 2023

A Retro-/Prospective, Non-interventional, Cohort Study in Adult

Active, not recruiting
  • Solid Tumor, Adult
  • +2 more
    • Amiens, France
    • +3 more
    Jul 22, 2022

    Solid Tumor Trial (TL118 Capsule)

    Not yet recruiting
    • Solid Tumor
    • TL118 Capsule
    • (no location specified)
    Aug 18, 2023

    NTRK Gene Fusion - Positive Advanced or Recurrent Solid

    Recruiting
    • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
    • Larotrectinib (Vitrakvi, BAY2757556)
    • Multiple Locations, Japan
      Many locations
    Jan 20, 2023

    Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

    Not yet recruiting
    • Advanced Cholangiocarcinoma
    • +2 more
    • (no location specified)
    Feb 3, 2023

    NTRK Family Gene Mutation Trial in Germany

    Recruiting
    • NTRK Family Gene Mutation
      • Berlin, Germany
      • +22 more
      Jan 18, 2023

      Called EPI VITRAKVI to Compare Treatment Results in Infantile

      Completed
      • Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
      • Infantile Fibrosarcoma
      • Larotrectinib (Vitrakvi, BAY2757556)
      • Standard of Care
      • Multiple Locations, France
        Multiple Locations
      Jan 10, 2023

      NSCLC, Solid Tumor Trial in Boston (Merestinib)

      Active, not recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Solid Tumor
      • Boston, Massachusetts
      • +1 more
      Jan 26, 2022

      Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic NSCLC Trial in Beijing (XZP-5955 tablets)

      Recruiting
      • Locally Advanced or Metastatic Solid Tumors
      • Locally Advanced or Metastatic Non-small Cell Lung Cancer
      • XZP-5955 tablets
      • Beijing, Beijing, China
        Cancer Hospital Chinese Academy of Medical Sciences
      May 17, 2022

      Solid Tumors Harboring NTRK Fusion Trial (Selitrectinib (BAY2731954))

      No longer available
      • Solid Tumors Harboring NTRK Fusion
      • Selitrectinib (BAY2731954)
      • (no location specified)
      Sep 8, 2021

      Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

      Recruiting
      • Breast Cancer
      • +15 more
      • Goodyear, Arizona
      • +146 more
      Aug 24, 2022

      NTRK Gene Fusion in Adult Brain Tumours

      Not yet recruiting
      • Glioma
      • Glioma data collection
      • Brain metastasis data collection
      • Marseille, France
        Hôpital Privé Clairval
      Aug 24, 2021

      Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)

      Recruiting
      • Soft Tissue Sarcoma
      • +2 more
      • Blood and tumor samples
      • Clermont-Ferrand, France
      • +9 more
      Dec 8, 2021

      Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (TPX-0005, Metformin Hydrochloride, Digoxin)

      Recruiting
      • Advanced Solid Tumor
      • Metastatic Solid Tumor
      • Canton, Ohio
        Gabrail Cancer Research Center
      Apr 25, 2023

      MRD Detection by NGS in Pediatric B-ALL

      Completed
      • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
      • MRD
      • Hangzhou, Zhejiang, China
        The Children's Hospital of Zhejiang University School of Medicin
      Jul 25, 2023

      Advanced Solid Malignant Tumors Trial in Fukuoka, Osaka, Tokyo (DS-6051b)

      Active, not recruiting
      • Advanced Solid Malignant Tumors
      • Fukuoka, Japan
      • +2 more
      Jan 18, 2022

      Either EML4-ALK Gene Rearrangements or T790M EGFR Mutation in

      Active, not recruiting
      • Carcinoma, Non-Small-Cell Lung
        • Hollywood, Florida
        • +1 more
        Sep 29, 2021

        Lung Cancer, EGFR Gene Mutation, EGFR Trial in Charlottesville (Sensus Smartwatch Application, RX Cap, Fitbit Sense)

        Recruiting
        • Lung Cancer
        • +3 more
        • Sensus Smartwatch Application
        • +3 more
        • Charlottesville, Virginia
          University of Virginia
        Aug 26, 2022

        Solid Tumor Trial in Beijing (AB-106)

        Recruiting
        • Solid Tumor
        • Beijing, China
          Chinese PLA General Hospital
        Jun 18, 2021

        Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Trial in Shanghai (SIM1803-1A)

        Recruiting
        • Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion
        • Shanghai, China
          Shanghai Chest Hospital
        Jan 11, 2021

        Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

        Recruiting
        • Cancer
        • +15 more
        • Data collection and quality of life questionnaire
        • Graz, Austria
        • +40 more
        Jul 27, 2021

        Advanced Cholangiocarcinoma, FGFR2 Gene Rearrangements Trial in Worldwide (TAS-120, Cisplatin/Gemcitabine)

        Active, not recruiting
        • Advanced Cholangiocarcinoma
        • FGFR2 Gene Rearrangements
        • Albuquerque, New Mexico
        • +100 more
        Feb 1, 2023

        Minimal Residual Disease(MRD)in Pediatric B-acute Lymphoblastic

        Recruiting
        • B Acute Lymphoblastic Leukemia
        • Minimal residual disease (MRD) monitoring
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Jul 25, 2021

        Diffuse Large B-cell Lymphoma, High-Grade B-cell Lymphoma Trial in Worldwide (RO6870810, Venetoclax, Rituximab)

        Completed
        • Diffuse Large B-cell Lymphoma
        • High-Grade B-cell Lymphoma
        • Duarte, California
        • +8 more
        Jan 21, 2022

        NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

        Not yet recruiting
        • Non-small Cell Lung Cancer (NSCLC)
        • MK-2870
        • +2 more
        • (no location specified)
        Oct 3, 2023